Clinical Trials
4
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:2
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 2
2 (50.0%)US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies
Phase 1
Recruiting
- Conditions
- High Risk Myeloid MalignanciesCord Blood Transplant
- Interventions
- Biological: ECT-001-CB (UM171-Expanded Cord Blood Transplant)
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- ExCellThera inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04990323
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease
Phase 1
Withdrawn
- Conditions
- Sickle Cell DiseaseUmbilical Cord BloodHematopoietic Cell Proliferation
- First Posted Date
- 2020-10-20
- Last Posted Date
- 2022-07-05
- Lead Sponsor
- ExCellThera inc.
- Registration Number
- NCT04594031
- Locations
- 🇺🇸
Stanford University School of Medicine, Palo Alto, California, United States
🇺🇸University of California San Francisco, San Francisco, California, United States
US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia
Phase 2
Active, not recruiting
- Conditions
- Cord Blood TransplantHigh Risk Hematological Malignancy
- Interventions
- Biological: ECT-001-CB (UM171-Expanded Cord Blood Transplant)
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- ExCellThera inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04103879
- Locations
- 🇺🇸
University of Colorado School of Medicine. Anschutz Medical Campus, Aurora, Colorado, United States
🇺🇸Fred Hutchinson / University of Washington Cancer Consortium, Seattle, Washington, United States
🇳🇱Erasmus Medical Center, Rotterdam, GD, Netherlands
News
No news found